{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:40:45Z","timestamp":1785865245112,"version":"3.56.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.semarthrit.2023.152269","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T11:32:33Z","timestamp":1695727953000},"page":"152269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Biologics in peripheral ulcerative keratitis"],"prefix":"10.1016","volume":"63","author":[{"given":"Daniel","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Manolios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6688-0480","authenticated-orcid":false,"given":"Chameen","family":"Samarawickrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.semarthrit.2023.152269_bib0001","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00003226-200009000-00008","article-title":"Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection","volume":"19","author":"Dana","year":"2000","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archopht.120.1.15","article-title":"Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy","volume":"120","author":"Sainz de la Maza","year":"1960","journal-title":"Arch Ophthalmol Chic Ill"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152269_bib0003","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0002-9394(79)90308-8","article-title":"Peripheral rheumatoid ulceration and evidence for conjunctival collagenase production","volume":"87","author":"Eiferman","year":"1979","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152269_bib0004","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","article-title":"Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression","volume":"91","author":"Foster","year":"1984","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152269_bib0005","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/bjophthalmol-2017-310671","article-title":"Corneal perforation from peripheral ulcerative keratopathy in patients with rheumatoid arthritis: epidemiological findings of the British ophthalmological surveillance unit","volume":"102","author":"Timlin","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152269_bib0006","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","article-title":"Ocular inflammatory diseases associated with rheumatoid arthritis","volume":"10","author":"Artifoni","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0007","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00003226-199001000-00013","article-title":"An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis","volume":"9","author":"Tauber","year":"1990","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0008","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2344\/0003-3006-60.1.25","article-title":"Basic and clinical pharmacology of glucocorticosteroids","volume":"60","author":"Becker","year":"2013","journal-title":"Anesth Prog"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152269_bib0009","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152269_bib0010","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00003226-199507000-00010","article-title":"Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management","volume":"14","author":"Messmer","year":"1995","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0011","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/ICO.0000000000000008","article-title":"Peripheral ulcerative keratitis and corneal melt: a 10-year single center review with historical comparison","volume":"33","author":"Knox Cartwright","year":"2014","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152269_bib0012","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.semarthrit.2020.03.023","article-title":"Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients","volume":"50","author":"Dominguez-Casas","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152269_bib0013","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3899\/jrheum.170437","article-title":"Clinical correlates, outcomes, and predictors of inflammatory ocular disease associated with rheumatoid arthritis in the biologic era","volume":"45","author":"Caimmi","year":"2018","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152269_bib0014","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/ICL.0000000000000906","article-title":"Visual outcomes of patients with peripheral ulcerative keratitis and the effect of immunosuppression-a 6-year experience in Queensland","volume":"48","author":"Li","year":"2022","journal-title":"Australia. Eye Contact Lens"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000486791","article-title":"Cyclophosphamide or rituximab treatment of scleritis and uveitis for patients with granulomatosis with polyangiitis","volume":"61","author":"Ahmed","year":"2019","journal-title":"Ophthalmic Res"},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152269_bib0016","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1097\/ICO.0000000000000919","article-title":"Successful treatment strategies in granulomatosis with polyangiitis-associated peripheral ulcerative keratitis","volume":"35","author":"Ebrahimiadib","year":"2016","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0017","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","article-title":"Resolving the clinical acuity categories \u201chand motion\u201d and \u201ccounting fingers\u201d using the Freiburg visual acuity test (FrACT)","volume":"247","author":"Lange","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152269_bib0018","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/112067210601600602","article-title":"Rheumatoid keratolysis: a series of 40 eyes","volume":"16","author":"Malik","year":"2006","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0019","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/ijo.IJO_1411_22","article-title":"Clinical profile and management of granulomatosis with polyangiitis-associated scleritis from a tertiary care hospital in South India","volume":"71","author":"Mohanan-Earatt","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001472","article-title":"Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis","volume":"7","author":"Bonnet","year":"2021","journal-title":"RMD Open"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152269_bib0021","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152269_bib0022","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/ICL.0000000000000770","article-title":"TNF-\u03b1 inhibitors for the management of intractable corneal melt: report of three cases and review of the literature","volume":"47","author":"Utine","year":"2021","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0023","doi-asserted-by":"crossref","unstructured":"Bench\u00e9rifa S., Amine B., El Binoune I., Rostom S., Bahiri R. Two cases of perforated corneal ulcers complicating rheumatoid arthritis treated successfully by biological therapy. BMC Rheumatol [Internet]; 2020 Feb 7 [cited 2020 Dec 29];4. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7006420\/.","DOI":"10.1186\/s41927-019-0108-1"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0024","article-title":"Concomitant herpes simplex keratitis and autoimmune-associated ulcerative keratitis in rheumatoid arthritis patients","volume":"18","author":"Yoshida","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152269_bib0025","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1080\/09273948.2017.1299869","article-title":"Anakinra in the treatment of patients with refractory scleritis: a pilot study","volume":"26","author":"Bottin","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152269_bib0026","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1055\/s-0043-123641","article-title":"Sj\u00f6gren's disease associated with severe retinal vasculitis and\/or necrotizing scleritis: two cases","volume":"235","author":"Lopez Baumann","year":"2018","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152269_bib0027","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1080\/09273948.2017.1327602","article-title":"Rituximab induction and maintenance treatment in patients with scleritis and granulomatosis with polyangiitis (Wegener's)","volume":"26","author":"You","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152269_bib0028","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjophthalmol-2016-308838","article-title":"Management of severe and refractory Mooren's ulcers with rituximab","volume":"101","author":"Guindolet","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152269_bib0029","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1055\/s-0042-121315","article-title":"Necrotising scleritis and peripheral ulcerative keratitis associated with rheumatoid arthritis treated with rituximab","volume":"234","author":"Hardy","year":"2017","journal-title":"Klin Monatsbl\u00e4tter F\u00fcr Augenheilkd"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152269_bib0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/1756-185X.12688","article-title":"Ulcerative keratitis in patients with rheumatoid arthritis in the modern biologic era: a series of eight cases and literature review","volume":"20","author":"Watanabe","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0031","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/APO.0000000000000036","article-title":"Infliximab in the treatment of refractory ocular inflammatory diseases","volume":"4","author":"Kam","year":"2015","journal-title":"Asia-Pac J Ophthalmol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152269_bib0032","first-page":"140","article-title":"Ipilimumab-induced ocular and orbital inflammation\u2013a case series and review of the literature","volume":"24","author":"Papavasileiou","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152269_bib0033","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00417-015-3198-5","article-title":"Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's)","volume":"253","author":"Recillas-Gispert","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152269_bib0034","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.rbr.2014.05.006","article-title":"Infliximabe \u00e9 eficaz em ceratite ulcerada perif\u00e9rica de dif\u00edcil controle. Um relato de tr\u00eas casos","volume":"55","author":"Zandavalli","year":"2015","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0035","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.2147\/OPTH.S51180","article-title":"Bilateral corneal ulceration in ocular graft-versus-host disease","volume":"7","author":"Stevenson","year":"2013","journal-title":"Clin Ophthalmol Auckl NZ"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152269_bib0036","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12348-012-0080-z","article-title":"Adalimumab for refractory peripheral ulcerative keratitis","volume":"2","author":"Cordero-Coma","year":"2012","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152269_bib0037","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.oftal.2011.01.003","article-title":"[Rituximab in rheumatoid arthritis-associated peripheral ulcerative keratitis]","volume":"86","author":"Albert","year":"2011","journal-title":"Arch Soc Espanola Oftalmol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152269_bib0038","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ajo.2011.01.059","article-title":"Use of infliximab in the treatment of peripheral ulcerative keratitis in Crohn disease","volume":"152","author":"Pham","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152269_bib0039","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bjo.2008.150961","article-title":"Infliximab for the treatment of refractory scleritis","volume":"94","author":"Doctor","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.ICL.0000092064.05514.04","article-title":"Recombinant human tumor necrosis factor receptor Fc fusion protein (Etanercept): experience as a therapy for sight-threatening scleritis and sterile corneal ulceration","volume":"30","author":"Hernandez-Illas","year":"2004","journal-title":"Eye Contact Lens"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152269_bib0041","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","article-title":"Tumor necrosis factor \u03b1 blockade with infliximab for refractory uveitis and scleritis","volume":"111","author":"Murphy","year":"2004","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152269_bib0042","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.ico.0000154391.28254.1d","article-title":"Therapy of progressive rheumatoid arthritis-associated corneal ulceration with infliximab","volume":"24","author":"Thomas","year":"2005","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0043","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/bjo.84.1.107","article-title":"Campath-1H therapy in refractory ocular inflammatory disease","volume":"84","author":"Dick","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152269_bib0044","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/meajo.meajo_180_22","article-title":"Peripheral subretinal mass complicating necrotizing anterior scleritis in a patient with granulomatosis with polyangiitis","volume":"29","author":"Alhazzani","year":"2023","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152269_bib0045","doi-asserted-by":"crossref","first-page":"e7595","DOI":"10.1002\/ccr3.7595","article-title":"ANCA-associated vasculitis with scleritis, corneal melt, and perforation rescued by rituximab: case report and literature review","volume":"11","author":"Matsuo","year":"2023","journal-title":"Clin Case Rep"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0046","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000529459","article-title":"The atypical red eye: a case of scleritis with peripheral ulcerative keratitis secondary to granulomatosis with polyangiitis","volume":"14","author":"Bonnet","year":"2023","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0047","first-page":"1","article-title":"Granulomatosis with polyangiitis-associated sclerokeratitis in a case of ocular adnexal B-cell lymphoma","author":"Valizadeh","year":"2023","journal-title":"Orbit Amst Neth"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0048","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221137126","article-title":"Baricitinib in severe and refractory peripheral ulcerative keratitis: a case report and literature review","volume":"14","author":"Calvo-R\u00edo","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0049","article-title":"Peripheral ulcerative keratitis, nodular episcleritis, and pulmonary nodules as the initial signs of rheumatic arthritis: a Case Report","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0050","doi-asserted-by":"crossref","DOI":"10.1093\/rap\/rkab068.020","article-title":"P21 My eye was cloudy at first and I can see it is melting away!","author":"Wong","year":"2021","journal-title":"Rheumatol Adv Pract"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152269_bib0051","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.4103\/ijo.IJO_2249_19","article-title":"Rituximab therapy combined with methotrexate for severe necrotizing scleritis in a case of granulomatosis with polyangiitis","volume":"68","author":"Murthy","year":"2020","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152269_bib0052","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.4103\/ijo.IJO_2081_18","article-title":"A case of idiopathic necrotizing scleritis with secondary glaucoma treated successfully with golimumab and Ahmed valve implantation","volume":"67","author":"Dutta Majumder","year":"2019","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152269_bib0053","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/ICO.0b013e318166f483","article-title":"Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody)","volume":"27","author":"Foerster","year":"2008","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152269_bib0054","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2169\/internalmedicine.0215-17","article-title":"Peripheral ulcerative keratitis associated with granulomatosis with polyangiitis emerging despite cyclophosphamide, successfully treated with rituximab","volume":"57","author":"Fujita","year":"2018","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0055","first-page":"51","article-title":"Queratitis ulcerativa perif\u00e9rica bilateral en paciente con artritis reumatoide: tratamiento con infliximab","volume":"91","author":"Aldasoro-C\u00e1ceres","year":"2017","journal-title":"Rev Mex Oftalmol"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152269_bib0056","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/ICO.0000000000000951","article-title":"Ocular manifestations of inherited phospholipase-C\u03b32\u2013associated antibody deficiency and immune dysregulation","volume":"35","author":"Zazzo","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0057","doi-asserted-by":"crossref","unstructured":"Eshraghi H., Mahtabfar A., Dastjerdi M.H. A case of peripheral ulcerative keratitis associated with autoimmune hepatitis. Case Rep Med [Internet]; 2017 [cited 2020 Dec 13]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5654256\/.","DOI":"10.1155\/2017\/3939413"},{"issue":"41","key":"10.1016\/j.semarthrit.2023.152269_bib0058","doi-asserted-by":"crossref","first-page":"e7951","DOI":"10.1097\/MD.0000000000007951","article-title":"Unique circumferential peripheral keratitis in relapsing polychondritis","volume":"96","author":"Motozawa","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0059","first-page":"44","article-title":"Use of rituximab for granulomatosis with polyangiitis-associated peripheral ulcerative keratitis","volume":"24","author":"Paulo Trujillo","year":"2017","journal-title":"Rev Colomb Reumatol Engl Ed"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152269_bib0060","first-page":"339","article-title":"Management of necrotizing scleritis after pterygium surgery with rituximab","volume":"79","author":"Fidelix TS de","year":"2016","journal-title":"Arq Bras Oftalmol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152269_bib0061","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/01676830.2015.1057290","article-title":"Bilateral orbital IgG4-related disease with systemic and corneal involvement showing an excellent response to steroid and rituximab therapy: report of a case with 11 years follow-up","volume":"34","author":"Berta","year":"2015","journal-title":"Orbit"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0062","doi-asserted-by":"crossref","unstructured":"Meadow P.B., Nguyen J., Kesavarapu K. Tofacitinib citrate for ulcerative keratitis in a patient with rheumatoid arthritis; Case Rep Rheumatol [Internet]. 2014 [cited 2021 Jan 8];2014. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4084676\/.","DOI":"10.1155\/2014\/403452"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0063","doi-asserted-by":"crossref","first-page":"523","DOI":"10.12659\/AJCR.891127","article-title":"Rheumatoid arthritis-associated corneal ulceration with superimposed infection by methicillin-resistant Staphylococcus aureus: a complicated type of corneal melt","volume":"15","author":"Singh","year":"2014","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0064","doi-asserted-by":"crossref","first-page":"318","DOI":"10.12659\/AJCR.883998","article-title":"Peripheral corneal ulceration associated with rheumatoid arthritis","volume":"14","author":"Karampatakis","year":"2013","journal-title":"Am J Case Rep"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152269_bib0065","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/ICO.0b013e31826218c7","article-title":"Atypical continuous keratitis in a case of rheumatoid arthritis accompanying severe scleritis","volume":"31","author":"Hata","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0066","doi-asserted-by":"crossref","unstructured":"Antao SF, Ayoub T., Tahir H., Parmar DN Stabilization of bilateral progressive rheumatoid corneal melt with infliximab. Case Rep Ophthalmol Med [Internet];2012 [cited 2020 Dec 13];2012. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3369392\/.","DOI":"10.1155\/2012\/173793"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152269_bib0067","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/09273948.2011.584653","article-title":"Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review","volume":"19","author":"Meskin","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152269_bib0068","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/ICO.0b013e3181c296ed","article-title":"Rituximab for peripheral ulcerative keratitis with wegener granulomatosis","volume":"29","author":"Huerva","year":"2010","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152269_bib0069","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09273941003739928","article-title":"Rituximab treatment for persistent scleritis associated with rheumatoid arthritis","volume":"18","author":"Iaccheri","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152269_bib0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/09273941003624914","article-title":"Infliximab in a patient with refractory necrotizing scleritis associated with relapsing polychondritis","volume":"18","author":"Jabbarvand","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0071","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/ICO.0b013e318181a84f","article-title":"Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-up","volume":"28","author":"Odorcic","year":"2009","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152269_bib0072","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.rhu.0000249766.24780.95","article-title":"Rheumatoid arthritis-associated necrotizing scleritis and peripheral ulcerative keratitis treated successfully with infliximab","volume":"12","author":"Atchia","year":"2006","journal-title":"JCR J Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152269_bib0073","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/ard.2010.144998","article-title":"Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis","volume":"70","author":"Buch","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0074","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/sonc.2003.50025","article-title":"The mechanisms of action of rituximab in the elimination of tumor cells","volume":"30","author":"Johnson","year":"2003","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152269_bib0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.pharmthera.2010.01.001","article-title":"Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers","volume":"125","author":"D\u00f6rner","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152269_bib0076","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152269_bib0077","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ophtha.2009.09.049","article-title":"Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report","volume":"117","author":"Foster","year":"2010","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152269_bib0078","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","article-title":"The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial","volume":"54","author":"Emery","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"31","key":"10.1016\/j.semarthrit.2023.152269_bib0079","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1200\/JCO.19.01073","article-title":"Sustained progression-free survival benefit of rituximab maintenance in patients with follicular lymphoma: long-term results of the PRIMA study","volume":"37","author":"Bachy","year":"2019","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152269_bib0080","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1136\/annrheumdis-2013-203480","article-title":"Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial","volume":"73","author":"Mariette","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0081","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/ard.2010.137703","article-title":"Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial","volume":"70","author":"Tak","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152269_bib0082","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/rheumatology\/kex446","article-title":"Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infection","volume":"57","author":"Henry","year":"2018","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152269_bib0083","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semarthrit.2018.02.010","article-title":"Predictors of hypogammaglobulinemia during rituximab maintenance therapy in rheumatoid arthritis: a 12-year longitudinal multi-center study","volume":"48","author":"Boleto","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152269_bib0084","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4169","article-title":"Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia","volume":"1","author":"Barmettler","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/BTT.S3189","article-title":"Infliximab in the treatment of rheumatoid arthritis","volume":"3","author":"Perdriger","year":"2009","journal-title":"Biol Targets Ther"},{"issue":"22","key":"10.1016\/j.semarthrit.2023.152269_bib0086","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152269_bib0087","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1111\/j.1572-0241.2002.07093.x","article-title":"Infliximab in the treatment of Crohn's disease: a user's guide for clinicians","volume":"97","author":"Sandborn","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152269_bib0088","first-page":"87","article-title":"Infliximab dosing patterns in a sample of patients with Crohn's disease: results from a medical chart review","volume":"7","author":"Tkacz","year":"2014","journal-title":"Am Health Drug Benefits"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152269_bib0089","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ajg.2010.9","article-title":"Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease","volume":"105","author":"Afif","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0090","unstructured":"TNF-\u03b1 blockade impairs in vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines [Internet] [cited;2021 Jul 25]. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0194430."},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152269_bib0091","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00427-18","article-title":"QuantiFERON-TB gold plus is a more sensitive screening tool than quantiferon-tb gold in-tube for latent tuberculosis infection among older adults in long-term care facilities","volume":"56","author":"Chien","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0092","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3899\/jrheum.140100","article-title":"Diagnostic accuracy of chest radiography for the diagnosis of tuberculosis (TB) and its role in the detection of latent TB infection: a systematic review","volume":"91","author":"Piccazzo","year":"2014","journal-title":"J Rheumatol Suppl"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152269_bib0093","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","article-title":"Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases","volume":"155","author":"Kirchgesner","year":"2018","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.semarthrit.2023.152269_bib0094","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2011.1692","article-title":"Initiation of tumor necrosis factor-\u03b1 antagonists and the risk of hospitalization for infection in patients with autoimmune diseases","volume":"306","author":"Grijalva","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152269_bib0095","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/rheumatology\/36.6.643","article-title":"Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy","volume":"36","author":"Brennan","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152269_bib0096","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1423-0127-21-12","article-title":"TNF-\u03b1 induces matrix metalloproteinase-9-dependent soluble intercellular adhesion molecule-1 release via TRAF2-mediated MAPKs and NF-\u03baB activation in osteoblast-like MC3T3-E1 cells","volume":"21","author":"Tsai","year":"2014","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.semarthrit.2023.152269_bib0097","unstructured":"Hospices Civils de Lyon. A multicenter randomized open-label trial comparing the efficacy and safety of infliximab versus cyclophosphamide in subjects with idiopathic refractory scleritis [Internet] clinicaltrials.gov; 2020 Jul [cited 2021 Jul 15]. Report No.: NCT03088293. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03088293."}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:11:30Z","timestamp":1758733890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017223001117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":97,"alternative-id":["S0049017223001117"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152269","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biologics in peripheral ulcerative keratitis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152269"}}